Testosterone Telehealth Requires Ops Platform

The hard part in TRT is not writing the first prescription, it is running the repeatable care loop after it. Testosterone is a controlled drug and dosing changes depend on fresh labs and follow up visits, so Hone has to coordinate blood draws, clinician review, refill timing, and add on medications inside one workflow. That makes the business look less like a simple online pharmacy and more like a tightly managed chronic care service.

• Ro’s early ED business was much lighter weight. A patient could fill out an async intake, get a clinician review, and receive generic sildenafil by mail, with Ro often monetizing mainly on drug fulfillment. That same flow could be copied across other simple prescription categories because little ongoing monitoring was needed.
  3 sacra 4 sacra
• Hone’s model is heavier because TRT usually starts with blood testing and then continues through quarterly follow up consults, lab evaluation, and medication adjustments. The company packages that work into a $129 to $149 monthly subscription, then layers on testosterone, anastrozole, and other therapies as the care plan evolves.
  1 sacra 2 sacra
• That operational burden also becomes a moat. As of the 2025 update, neither Ro nor Hims had a competitive TRT or menopause HRT offering because their high volume virtual prescription systems were not built around blood draws, lab interpretation, and recurring hormone management. Hone has used that infrastructure to expand into GLP-1s, metformin, glutathione, and women’s hormones.
  2 sacra 3 sacra

The next phase is for hormone telehealth to keep moving toward a broader managed care model. The winners will be the companies that turn lab collection, clinician follow up, and medication fulfillment into one low friction system, then reuse that system across adjacent long duration therapies where retention and lifetime value are naturally much higher than in one off generic drug businesses.